We mined Bayer’s acquisitions, investments, and partnerships to discern the company's strategic priorities.
Bayer is one of the largest pharmaceutical companies in the world by market cap.
Over the last few years, Bayer has forged business relationships with other organizations to help prevent, diagnose, alleviate, and cure diseases.
One goal unifying Bayer’s activity is that it is looking to expand beyond traditional drug discovery and development. To do so, the pharma giant is rapidly tapping into a variety of emerging technologies, including digital therapeutics, real-world data, and artificial intelligence.
Using CB Insights data, we uncovered the 4 most important strategic priorities in healthcare highlighted by Bayer’s recent acquisitions, investments, and partnerships. We then categorized companies by their business relationships with Bayer across these priorities.
- Digital therapeutics & wellness
- Drug discovery & development
- Monitoring & diagnostics
- Real-world data
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.
